benzoxazoles has been researched along with Leukemia in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Can, H; Ertan-Bolelli, T; Oksuzoglu, E; Ozturk, K; Tarhan, M; Yildiz, I | 1 |
An, D; Chen, J; He, B; Li, M; Liu, P; Meng, L; Zhang, X; Zhang, Y; Zhao, J | 1 |
Easton, TG; Reich, E; Valinsky, JE | 1 |
3 other study(ies) available for benzoxazoles and Leukemia
Article | Year |
---|---|
Antitumor activities on HL-60 human leukemia cell line, molecular docking, and quantum-chemical calculations of some sulfonamide-benzoxazoles.
Topics: Antineoplastic Agents; Apoptosis; Benzoxazoles; Cell Proliferation; DNA Topoisomerases, Type II; Drug Screening Assays, Antitumor; HL-60 Cells; Humans; Leukemia; Molecular Docking Simulation; Nucleic Acid Conformation; Protein Conformation; Quantum Theory; Structure-Activity Relationship; Sulfonamides | 2017 |
The role of P2X7 receptor in ATP-mediated human leukemia cell death: calcium influx-independent.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenosine Triphosphate; Apoptosis; Benzoxazoles; Biological Transport; Calcium; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Flow Cytometry; Humans; Leukemia; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Quinolinium Compounds; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Spectrometry, Fluorescence; Time Factors | 2009 |
Merocyanine 540 as a fluorescent probe of membranes: selective staining of leukemic and immature hemopoietic cells.
Topics: Benzoxazoles; Blood Platelets; Calcium; Erythrocytes; Fluorescent Dyes; Hematopoietic Stem Cells; Humans; Ionophores; Kinetics; Leukemia; Leukocytes; Light; Oxygen; Pyrimidinones; Staining and Labeling | 1978 |